We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 46

Canada’s PAAB releases updated Code of Advertising Acceptance

  • Torys LLP
  • -
  • Canada
  • -
  • December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Product liability litigation: bar raised for class action certification?

  • Torys LLP
  • -
  • Canada
  • -
  • May 10 2012

In a decision released May 7, 2012, Justice Caroline Horkins of the Superior Court of Ontario has refused to certify a proposed class proceeding in a pharmaceutical product liability claim (Martin et al. v. Astrazeneca Pharmaceuticals PLC et al

Canada's version of the responsible corporate officer doctrine: can officers be held responsible for pharma violations?

  • Torys LLP
  • -
  • Canada, USA
  • -
  • February 29 2012

In March 2010, the United States Food and Drug Administration (FDA) announced its intention to rely more heavily on the "responsible corporate officer" (RCO) doctrine to prosecute individuals for violations of the federal Food, Drug and Cosmetic Act (FDCA

Canada's approach to functional foods

  • Torys LLP
  • -
  • Canada
  • -
  • April 21 2010

Today’s diet- and health-conscious environment has led to a proliferation of functional food marketing claims that advertise the specific health-enhancing characteristics of a food product

Canada to change the regulation of “food-like" natural health products

  • Torys LLP
  • -
  • Canada
  • -
  • April 24 2012

On April 17, 2012, Health Canada announced that it will classify and transition all "food-like" natural health products (NHPs) to the regulatory framework that governs the sale of food products in Canada

Producers to manage pharmaceuticals and sharps returned by consumers

  • Torys LLP
  • -
  • Canada
  • -
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force

Ontario case on product liability shows the immense scope of a class action trial

  • Torys LLP
  • -
  • Canada
  • -
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial

Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations

  • Torys LLP
  • -
  • Canada
  • -
  • April 29 2008

On April 26, 2008, the government of Canada published for comment proposed amendments to the Patented Medicines (Notice of Compliance) Regulations, commonly referred to as the “PM(NOC) Regulations.”

Canada amends regulations on adverse drug reaction reporting

  • Torys LLP
  • -
  • Canada
  • -
  • March 11 2011

Amended regulations regarding the reporting of adverse drug reactions came into force on February 10, 2011

Health Canada’s guidance document on PM(NOC) Regulations now finalized

  • Torys LLP
  • -
  • Canada
  • -
  • April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations